These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4604345)

  • 21. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of pyridoxylate in patients with severe cerebral arteriosclerosis (results of a double blind trial)].
    Cottin S; Prost A; Lefevre M; Auvinet B
    Sem Hop Ther; 1974 Jan; 50(1):41-4. PubMed ID: 4603511
    [No Abstract]   [Full Text] [Related]  

  • 23. [Does Dusodril elevate cerebral ATP-contents? (author's transl)].
    Fischer JH; Isselhard W
    Klin Wochenschr; 1974 Nov; 52(22):1088-90. PubMed ID: 4444226
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of pentetrazole on serum cholesterol level and on behavior of patients with cerebral arteriosclerosis].
    Merkus JW
    Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1634-8. PubMed ID: 4878453
    [No Abstract]   [Full Text] [Related]  

  • 27. [Naphthydrofuryl in neurology].
    Ahumada BH
    Prensa Med Argent; 1971 Jul; 58(21):1067-70. PubMed ID: 5096690
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind study of the effect of ribonucleic acid in senile brain disease.
    Nodine JH; Shulkin MW; Slap JW; Levine M; Freiberg K
    Am J Psychiatry; 1967 Apr; 123(10):1257-9. PubMed ID: 5336625
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
    Brodie NH
    Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical evaluation of naproxen in the treatment of osteoarthritis--double-blind, controlled, cross-over trial].
    Kageyama T
    Ryumachi; 1974 Jul; 14(2):106-20. PubMed ID: 4616372
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study.
    Enger E; Boyesen S
    Acta Med Scand Suppl; 1965; 438():1-61. PubMed ID: 5323519
    [No Abstract]   [Full Text] [Related]  

  • 32. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
    Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Angiodilatator therapy in otology: value of Praxilene].
    Bordes LR; Baradat P; Lienhart H; Debrie JC
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(11):858-63. PubMed ID: 5151167
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of cerebral insufficiency].
    Grill P; Broicher H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669
    [No Abstract]   [Full Text] [Related]  

  • 39. [Naproxen--a new antiphlogistic].
    Szanto E
    Lakartidningen; 1974 Oct; 71(40):3789-91. PubMed ID: 4605807
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of vasopressin in the asthenic syndrome of cerebral arteriosclerosis].
    Akimov GA; Medvedev VI; Stepovik NV; Bakharev VD; Kaurov OA
    Sov Med; 1982; (1):49-52. PubMed ID: 7063941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.